Prior to EEN initiation, patients with Crohn’s disease had significantly higher plasma iFABP concentrations than Controls (plasma iFABP EEN Start: 1339 pg/mL [895, 1969] vs Controls: 938 pg/mL [616, 1140], p = 0.008). This evidence concerns the gene FABP2 and Crohn disease.